日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune checkpoint inhibitor rechallenge in advanced NSCLC: prognostic value of the neutrophil-to-lymphocyte ratio

晚期非小细胞肺癌患者再次接受免疫检查点抑制剂治疗:中性粒细胞与淋巴细胞比值的预后价值

Minami, Soichiro; Yamazaki, Yusuke; Saito, Shin; Toi, Yukihiro; Fukuzawa, Keito; Doman, Tsuyoshi; Narumi, Akane; Odaka, Tetsuo; Ogasawara, Takahiro; Shimizu, Hisashi; Sugisaka, Jun; Ono, Kana; Aiba, Tomoiki; Kawana, Sachiko; Yamanda, Shinsuke; Kimura, Yuichiro; Sugawara, Shunichi

Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC

血清 VEGF-A 作为转移性非小细胞肺癌化疗联合免疫治疗中加用贝伐单抗的生物标志物

Tanaka, Kentaro; Sugisaka, Jun; Shiraishi, Yoshimasa; Watanabe, Yasutaka; Daga, Haruko; Azuma, Koichi; Nishino, Kazumi; Mori, Masahide; Ota, Takayo; Saito, Haruhiro; Hata, Akito; Sakaguchi, Tadashi; Kozuki, Toshiyuki; Akamatsu, Hiroaki; Matsumoto, Hirotaka; Tachihara, Motoko; Wakuda, Kazushige; Sato, Yuki; Ozaki, Tomohiro; Tsuchiya-Kawano, Yuko; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko; Okamoto, Isamu

Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry)

EGFR酪氨酸激酶抑制剂对EGFR 19号外显子插入的非小细胞肺癌患者的疗效:通过LC-SCRUM-Asia(多机构基因组筛查登记)进行的临床基因组学和临床前分析

Uehara, Yuji; Izumi, Hiroki; Kobayashi, Ikei S; Matsumoto, Shingo; Hosomi, Yukio; Okuno, Takae; Sugisaka, Jun; Takase, Naoto; Taima, Kageaki; Sasaki, Shinichi; Teranishi, Shuhei; Miyamoto, Shingo; Mori, Masahide; Nakashima, Chiho; Asano, Shuichi; Oi, Hajime; Sakai, Tetsuya; Shibata, Yuji; Udagawa, Hibiki; Sugiyama, Eri; Nosaki, Kaname; Umemura, Shigeki; Zenke, Yoshitaka; Yoh, Kiyotaka; Ikeda, Sadakatsu; Costa, Daniel B; Kobayashi, Susumu S; Goto, Koichi

Real-world outcomes and association between immune-related adverse events and therapeutic efficacy of nivolumab plus ipilimumab in elderly patients (≥75 years) with advanced non-small cell lung cancer

真实世界结果以及免疫相关不良事件与老年(≥75岁)晚期非小细胞肺癌患者接受纳武利尤单抗联合伊匹木单抗治疗疗效之间的关联

Minami, Soichiro; Doman, Tsuyoshi; Toi, Yukihiro; Fukuzawa, Keito; Yamazaki, Yusuke; Saito, Shin; Narumi, Akane; Odaka, Tetsuo; Ogasawara, Takahiro; Shimizu, Hisashi; Sugisaka, Jun; Ono, Kana; Aiba, Tomoiki; Kawana, Sachiko; Yamanda, Shinsuke; Kimura, Yuichiro; Sugawara, Shunichi

Efficacy and safety of immune checkpoint inhibitors in advanced non-small cell lung cancer with idiopathic interstitial pneumonia or interstitial lung abnormalities: NJLCG2301

免疫检查点抑制剂治疗伴有特发性间质性肺炎或间质性肺异常的晚期非小细胞肺癌的疗效和安全性:NJLCG2301

Okumura, Fumihiko; Tanaka, Hisashi; Onodera, Katsuhiro; Morita, Ryo; Inomata, Minehiko; Suzuki, Aya; Sugisaka, Jun; Minemura, Hiroyuki; Jingu, Daisuke; Kudo, Satoshi; Kikuchi, Hajime; Yoshimura, Naruo; Tsushima, Fumiyasu; Kakeda, Shingo; Tasaka, Sadatomo

A case of lower respiratory tract infection caused by Pandoraea sputorum in a human T-lymphotropic virus type 1 carrier

一例由潘多拉菌(Pandoraea sputorum)引起的人类T淋巴细胞病毒1型携带者下呼吸道感染病例

Ogasawara, Takahiro; Yamanda, Shinsuke; Fukuzawa, Keito; Yamazaki, Yusuke; Doman, Tsuyoshi; Minami, Soichiro; Narumi, Akane; Saito, Shin; Odaka, Tetsuo; Ono, Kana; Shimizu, Hisashi; Sugisaka, Jun; Aiba, Tomoiki; Kawana, Sachiko; Toi, Yukihiro; Sugawara, Shunichi; Kimura, Yuichiro

Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer

老年晚期非小细胞肺癌患者的免疫疗法或化疗免疫疗法

Tsukita, Yoko; Tozuka, Takehiro; Kushiro, Kohei; Hosokawa, Shinobu; Sumi, Toshiyuki; Uematsu, Mao; Honjo, Osamu; Yamaguchi, Ou; Asao, Tetsuhiko; Sugisaka, Jun; Saito, Go; Shiihara, Jun; Morita, Ryo; Katakura, Seigo; Yasuda, Takehiro; Hisakane, Kakeru; Miyauchi, Eisaku; Morita, Satoshi; Kobayashi, Kunihiko; Asahina, Hajime

Seasonal switching of integrated leaf senescence controls in an evergreen perennial Arabidopsis

常绿多年生拟南芥叶片衰老综合控制的季节性转换

Genki Yumoto, Haruki Nishio, Tomoaki Muranaka, Jiro Sugisaka, Mie N Honjo, Hiroshi Kudoh

Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer

利用机器学习分析病理图像预测小细胞肺癌患者接受免疫治疗后的1年无进展生存期

Shibaki, Ryota; Fujimoto, Daichi; Nozawa, Tsukasa; Sano, Akira; Kitamura, Yuka; Fukuoka, Junya; Sato, Yuki; Kijima, Takashi; Matsumoto, Hirotaka; Yokoyama, Toshihide; Miura, Satoru; Hata, Akito; Tamiya, Motohiro; Taniguchi, Yoshihiko; Sugisaka, Jun; Furuya, Naoki; Tanaka, Hisashi; Yamamoto, Nobuyuki; Koh, Yasuhiro; Akamatsu, Hiroaki

Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101)

EGFR 突变型非小细胞肺癌患者接受放化疗后使用度伐利尤单抗治疗:一项真实世界研究 (HOT2101)

Tsuji, Kosuke; Mizugaki, Hidenori; Yokoo, Keiki; Kobayashi, Maki; Kawashima, Yosuke; Kimura, Nozomu; Yokouchi, Hiroshi; Kikuchi, Hajime; Sumi, Toshiyuki; Kawai, Yasutaka; Kobashi, Kenta; Morita, Ryo; Ito, Kenichiro; Kitamura, Yasuo; Minemura, Hiroyuki; Nakamura, Keiichi; Aso, Mari; Honjo, Osamu; Tanaka, Hisashi; Takashina, Taichi; Tsurumi, Kyoji; Sugisaka, Jun; Tsukita, Yoko; Konno, Satoshi; Oizumi, Satoshi